We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
UNIFI
UFI
$132M
| $294K | ﹤0.01% |
+34,157
| New | +$294K |
|
|
CALY
1977
Callaway Golf Company
CALY
$3.04B
| $294K | ﹤0.01% |
15,182
-155,164
| -91% | -$3.06M |
|
1978
Krystal Biotech
KRYS
$9.71B
| $294K | ﹤0.01% |
+3,708
| New | +$275K |
|
1979
Global Industrial
GIC
$1.54B
| $291K | ﹤0.01% |
12,361
-6,893
| -36% | -$179K |
|
1980
Editas Medicine
EDIT
$441M
| $291K | ﹤0.01% |
+32,762
| New | +$360K |
|
1981
XPEL
XPEL
$1.34B
| $290K | ﹤0.01% |
4,824
+1,138
| +31% | +$72.7K |
|
|
SLGC
1982
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $288K | ﹤0.01% |
+114,925
| New | +$321K |
|
1983
Rapid7
RPD
$956M
| $287K | ﹤0.01% |
+8,455
| New | +$302K |
|
1984
BioCryst Pharmaceuticals
BCRX
$2.66B
| $287K | ﹤0.01% |
24,992
+2,432
| +11% | +$30.3K |
|
|
CSTR
1985
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $287K | ﹤0.01% |
16,239
+2,170
| +15% | +$38.5K |
|
|
FPI
1986
Farmland Partners
FPI
$426M
| $286K | ﹤0.01% |
22,927
+2,641
| +13% | +$34.9K |
|
1987
PCB Bancorp
PCB
$389M
| $285K | ﹤0.01% |
16,095
-9,798
| -38% | -$182K |
|
1988
AtriCure
ATRC
$2.13B
| $285K | ﹤0.01% |
6,412
-2,085
| -25% | -$87.1K |
|
|
DEA
1989
Easterly Government Properties
DEA
$1.14B
| $283K | ﹤0.01% |
7,938
+642
| +9% | +$25K |
|
1990
Astec Industries
ASTE
$1B
| $283K | ﹤0.01% |
+6,958
| New | +$281K |
|
1991
Ionis Pharmaceuticals
IONS
$9.35B
| $282K | ﹤0.01% |
7,569
-141
| -2% | -$5.93K |
|
1992
Innovative Industrial Properties
IIPR
$1.67B
| $281K | ﹤0.01% |
2,769
-784
| -22% | -$83.5K |
|
|
AYX
1993
DELISTED
Alteryx Inc
AYX
| $279K | ﹤0.01% |
5,610
-4,382
| -44% | -$209K |
|
1994
Aterian
ATER
$5.1M
| $279K | ﹤0.01% |
30,186
+29,098
| +2,674% | +$365K |
|
1995
Companhia Siderúrgica Nacional
SID
$1.18B
| $279K | ﹤0.01% |
101,076
-3,151
| -3% | -$8.47K |
|
1996
Mirum Pharmaceuticals
MIRM
$6.07B
| $279K | ﹤0.01% |
14,299
+3,579
| +33% | +$70.7K |
|
1997
Mine Safety
MSA
$7.56B
| $275K | ﹤0.01% |
1,918
-378
| -16% | -$49.5K |
|
|
FOCS
1998
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $274K | ﹤0.01% |
7,361
-6,071
| -45% | -$216K |
|
1999
Coastal Financial
CCB
$777M
| $273K | ﹤0.01% |
5,753
+54
| +0.9% | +$2.5K |
|
2000
Agilysys
AGYS
$3.05B
| $273K | ﹤0.01% |
3,452
-1,774
| -34% | -$113K |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.